The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Result configuration
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
Insilicogen
Yongin-si, South Korea
A
11-50 Employees
2005
Key takeaway
Insilicogen has dedicated the past 20 years to building extensive bio big data, positioning itself as a key player in the field. This expertise in data production, archiving, modeling, and analysis is essential for advancements in synthetic biology.
Reference
Product
Solution | Insilicogen, Inc.
New Era for Bioinformatics
Spidercore Inc.
Daejeon, South Korea
A
1-10 Employees
2020
Key takeaway
Spidercore's S.Core platform utilizes a hyper-scale AI engine to analyze nucleotide properties, aiming to enhance the development of gene therapies. Their focus on AI-driven decision support in biomedical care highlights the potential of synthetic biology in improving treatment outcomes and making advanced therapies more accessible.
Reference
Core business
Spidercore Inc.
Onegene Biotechnology
Seongnam-si, South Korea
A
- Employees
2016
Key takeaway
Onegene Biotechnology is at the forefront of research and development in the biotech field, focusing on multi-target drug development through innovative approaches that combine chemistry and protein engineering. Their flagship program, OGB21502, exemplifies their commitment to advancing treatment for complex diseases, which aligns with the principles of synthetic biology.
Reference
Core business
ONEGENE BIOTECHNOLOGY
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
MxT Biotech
Seoul, South Korea
A
1-10 Employees
2021
Key takeaway
MxT Biotech specializes in synthetic biology through its innovative Hydroporator® platform, which enables highly effective non-viral delivery of genetic materials and proteins into primary cells, thus advancing gene editing and cellular engineering for applications like cancer immunotherapy. Their focus on microfluidics and gene editing positions them at the forefront of therapeutic development.
Reference
Core business
MxT Biotech :: Microfluidics x Therapy
We transform cancer immunotherapy, cellular engineering and genome editing with our patented non-viral genome editing technology, Hydroporator .
BIORCHESTRA
Chungju-si, South Korea
A
1-10 Employees
2016
Key takeaway
BIORCHESTRA focuses on developing innovative RNA medicines and delivery systems that address significant medical needs, particularly in neurodegenerative and rare diseases of the Central Nervous System. Their advanced technology enhances the targeted delivery of RNA therapeutics, offering hope for patients with previously neglected conditions.
Reference
Core business
BIORCHESTRA – Innovative RNA Therapeutics
Clecell co.ltd
Seongnam-si, South Korea
A
11-50 Employees
2016
Key takeaway
The company is at the forefront of synthetic biology through its innovative bioprinting platform, which enables the creation of artificial human tissues and organoids. Their technology is revolutionizing personalized and regenerative medicine, particularly in developing realistic in vitro models for cancer testing and reducing the need for animal testing.
Reference
Core business
CLECELL | Biotechnology company | South Korea
CLECELL is trailblazing the field of personalized and regenerative medicine with our revolutionary bioprinting and tissue engineering technology.
Koram Biotech & Koram Biogen Corp
Seoul, South Korea
A
51-100 Employees
1988
Key takeaway
NEB (New England Biolabs) offers GMP-grade products that adhere to ISO 9001 and ISO 13485:2016 quality management standards, ensuring high lot-to-lot consistency through qualified equipment and controlled manufacturing processes.
Reference
Product
ATCC
N-BIOTEK
Bucheon-si, South Korea
A
51-100 Employees
-
Key takeaway
N-BIOTEK is a leading company in life science and regenerative medicine, offering a comprehensive 'Stem Cell Total Solution' that includes advanced stem cell culture technology and equipment. Their expertise in developing life science equipment and commitment to ethical management positions them as a key player in the field of synthetic biology.
Reference
Product
Stem Cell Isolation Package - Lab Equipment - N-BIOTEK
N-BIOTEK
Orient Bio
Seongnam-si, South Korea
A
101-250 Employees
1959
Key takeaway
Orient Bio provides high-quality biological materials and related services, positioning itself as a leader in the burgeoning synthetic biology industry. Their one-stop, tailored solutions meet researchers' needs, supporting innovative developments in this field.
Reference
Core business
오리엔트 바이오
국제표준의 고품질 생물소재를 제공하고 그와 연관된 바이오 서비스를 하고 있습니다.
Narnialabs
South Korea
A
11-50 Employees
2022
Key takeaway
Narnia Labs leverages AI-powered Generative Design technology to enhance product development, offering solutions that minimize costs and time through design generation and optimization. Their approach to engineering and industrial design can foster innovation and streamline the design process.
Reference
Core business
Narnia Labs | AI-powered Product Design
Technologies which have been searched by others and may be interesting for you:
When exploring the Synthetic Biology industry in South Korea, several key considerations come into play. Regulatory frameworks are crucial, as the South Korean government has established guidelines to ensure safety and efficacy in genetic engineering and biomanufacturing. Understanding these regulations is essential for compliance and successful market entry. The competitive landscape is vibrant, with numerous research institutions and startups driving innovation. Collaborations between academia and industry can offer valuable insights and advancements in technology. Environmental concerns also play a significant role; companies are increasingly focused on sustainable practices and minimizing ecological impacts, which can enhance their market appeal. Additionally, the global market relevance of South Korea’s Synthetic Biology sector is noteworthy, as it positions itself as a leader in biopharmaceuticals and agricultural biotechnology. The growing demand for bio-based solutions offers opportunities for expansion and innovation, particularly in health and nutrition sectors. However, challenges such as funding, talent acquisition, and navigating complex international markets must be addressed. Overall, a thorough understanding of these factors can significantly aid in making informed decisions within South Korea's dynamic Synthetic Biology industry.
Some interesting numbers and facts about your company results for Synthetic Biology
Country with most fitting companies | South Korea |
Amount of fitting manufacturers | 26 |
Amount of suitable service providers | 9 |
Average amount of employees | 11-50 |
Oldest suiting company | 1959 |
Youngest suiting company | 2022 |
Some interesting questions that has been asked about the results you have just received for Synthetic Biology
What are related technologies to Synthetic Biology?
Based on our calculations related technologies to Synthetic Biology are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Who are Start-Ups in the field of Synthetic Biology?
Start-Ups who are working in Synthetic Biology are MxT Biotech, Narnialabs
Which industries are mostly working on Synthetic Biology?
The most represented industries which are working in Synthetic Biology are Biotechnology, Other, IT, Software and Services, Automation, Chemicals
How does ensun find these Synthetic Biology Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.